UMMS Affiliation
Commonwealth Medicine, Clinical Pharmacy Services
Publication Date
2019-04-10
Document Type
Blog Post
Disciplines
Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Pharmacy Administration, Policy and Regulation
Abstract
Earlier this year, the Department of Health and Human Services (HHS) proposed changes to the current pricing and contracting system for federal health care programs, Medicare Part D and Medicaid.This proposal aligns with the Trump Administration’s blueprint for lowering drug prices which we have written about previously.
Keywords
prescription drug rebates, list prices, patients, out-of-pocket costs, drug companies, pharmacy benefit managers
Rights and Permissions
© 2019 University of Massachusetts Medical School
Journal/Book/Conference Title
Commonwealth Medicine Blog
Repository Citation
Taylor, Mckenzie and Tran, Stephanie, "Will ending certain drug rebates lower list prices and patient out-of-pocket costs?" (2019). Commonwealth Medicine Publications. 237.
https://escholarship.umassmed.edu/commed_pubs/237
Included in
Health Economics Commons, Health Law and Policy Commons, Health Policy Commons, Health Services Administration Commons, Health Services Research Commons, Pharmacy Administration, Policy and Regulation Commons
Comments
Blog post to Commonwealth Medicine's website - view blog post online